Berlin, December 7, 2022-Current recommendations on the supply bottleneck of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

被引：0
|
作者：
不详
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
PANCREATIC-CANCER; CHEMOTHERAPY; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I：
10.1055/a-1998-7964
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [21] Phase II trial of nab-paclitaxel (nanoparticle albumin-bound paclitaxel (ABX)) plus capecitabine (XEL) in first-line treatment of metastatic breast cancer (MBC)
    Somer, B. G.
    Schwartzberg, L. S.
    Arena, F.
    Epperson, A.
    Fu, D.
    Fortner, B. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Saxena, Ashish
    Schneider, Bryan J.
    Christos, Paul J.
    Audibert, Lauren F.
    Cagney, Jennifer M.
    Scheff, Ronald J.
    MEDICAL ONCOLOGY, 2016, 33 (02) : 1 - 9
  • [23] Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent
    Ashish Saxena
    Bryan J. Schneider
    Paul J. Christos
    Lauren F. Audibert
    Jennifer M. Cagney
    Ronald J. Scheff
    Medical Oncology, 2016, 33
  • [24] Nanoparticle Albumin-Bound Paclitaxel is More Effective Than Paclitaxel in Experimental Endometrial Cancer
    Huang, Jing
    Huo, Hongqi
    Chen, Mulan
    Wang, Lili
    Li, Nani
    Huang, Zhijian
    Yang, Lin
    SCIENCE OF ADVANCED MATERIALS, 2022, 14 (05) : 829 - 835
  • [25] Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer
    Zhang, Weiwei
    Xu, Yinggang
    Shi, Xiaoqing
    Huang, Xiaofeng
    Chen, Rui
    Xu, Haiping
    Shi, Wenjie
    Wan, Xinyu
    Wang, Ye
    He, Jinzhi
    Li, Cuiying
    Wang, Jue
    Zha, Xiaoming
    NANOMEDICINE, 2022, 17 (10) : 683 - 694
  • [26] Nanoparticle albumin-bound paclitaxel for treatment of metastatic breast cancer
    Pinder, Mary C.
    Ibrahim, Nuhad K.
    DRUGS OF TODAY, 2006, 42 (09) : 599 - 604
  • [27] Overview of nanoparticle albumin-bound paclitaxel in metastatic breast cancer
    Strauch, Demetria Ileana
    Moreno-Aspitia, Alvaro
    BREAST CANCER MANAGEMENT, 2013, 2 (03) : 221 - 229
  • [28] A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer
    Nanda, R.
    Chennamaneni, P.
    Gibson, J.
    Koetter, K.
    Libao, B.
    Skor, M.
    Maranville, J.
    Hoffman, P.
    Obeid, E.
    DiRienzo, A.
    Fleming, G.
    Conzen, S.
    CANCER RESEARCH, 2013, 73
  • [29] DIFFERENT PATTERNS OF TREATMENT WITH ALBUMIN-BOUND PACLITAXEL (NAB-PACLITAXEL) FOR TARGETED CHEMOTHERAPY IN METASTATIC BREAST CANCER: A MULTICENTER ITALIAN EXPERIENCE ON 125 WOMEN
    Palumbo, Raffaella
    Cazzaniga, Marina
    Piazza, Elena
    Tondini, Carlo
    Ferzi, Antonella
    Grasso, Donatella
    Danova, Marco
    Tarenzi, Emiliana
    Sottotetti, Federico
    Villa, Federica
    Gambaro, Anna
    Caremoli, Elena Rota
    Collova, Elena
    Cavalli, Carla
    Bernardo, Antonio
    BREAST, 2013, 22 : S41 - S41
  • [30] A phase I dose escalation study of a 2 day lapatinib chemosensitization pulse preceding weekly intravenous nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in patients with advanced cancer
    Chien, A. J.
    Illi, J. A.
    Ko, A. H.
    Dubey, S.
    Jahan, T. M.
    Hylton, N. M.
    Yeh, B. M.
    Huang, Y.
    Koch, K. M.
    Moasser, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345